Daniel R. Passeri's most recent trade in Cue Biopharma Inc was a trade of 450,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on March 21, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cue Biopharma Inc | Daniel R. Passeri | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2025 | 450,000 | 450,000 | - | - | Stock Option (right to buy) | |
| Cue Biopharma Inc | R. Daniel Passeri | Director, CHIEF EXECUTIVE OFFICER | 16 Dec 2024 | 30,000 | 164,578 (0%) | 0% | 1.0 | 30,900 | Common Stock | |
| Cue Biopharma Inc | Daniel R. Passeri | Director, CHIEF EXECUTIVE OFFICER | 06 Mar 2024 | 400,000 | 400,000 | - | - | Stock Option (right to buy) | ||
| Cue Biopharma Inc | Daniel R. Passeri | Director, CHIEF EXECUTIVE OFFICER | 14 Aug 2023 | 3,000 | 134,578 (0%) | 0% | 2.9 | 8,580 | Common Stock | |
| Cue Biopharma Inc | Daniel R. Passeri | Director, CHIEF EXECUTIVE OFFICER | 21 Jul 2023 | 450,000 | 450,000 | - | - | Stock Option (right to buy) | ||
| Cue Biopharma Inc | Daniel R. Passeri | Director, CHIEF EXECUTIVE OFFICER | 16 Feb 2023 | 324,000 | 324,000 | - | - | Stock Option (right to buy) | ||
| Cue Biopharma Inc | Daniel R. Passeri | Director, CHIEF EXECUTIVE OFFICER | 31 Mar 2022 | 75,000 | 173,700 (0%) | 0% | - | Common Stock | ||
| Cue Biopharma Inc | Daniel R. Passeri | Director, CHIEF EXECUTIVE OFFICER | 31 Mar 2022 | 75,000 | 0 | - | - | Restricted Stock Units | ||
| Cue Biopharma Inc | Daniel R. Passeri | Director, CHIEF EXECUTIVE OFFICER | 31 Mar 2022 | 32,122 | 141,578 (0%) | 0% | 4.9 | 156,755 | Common Stock | |
| Cue Biopharma Inc | Daniel R. Passeri | Director, CHIEF EXECUTIVE OFFICER | 31 Mar 2022 | 10,000 | 131,578 (0%) | 0% | 0 | Common Stock | ||
| Cue Biopharma Inc | Daniel R. Passeri | Director, CHIEF EXECUTIVE OFFICER | 25 Mar 2022 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | ||
| Cue Biopharma Inc | Daniel R. Passeri | Director, CHIEF EXECUTIVE OFFICER | 30 Sep 2021 | 75,000 | 75,000 | - | - | Restricted Stock Units | ||
| Cue Biopharma Inc | Daniel R. Passeri | Director, CHIEF EXECUTIVE OFFICER | 30 Sep 2021 | 75,000 | 130,377 (0%) | 0% | - | Common Stock | ||
| Cue Biopharma Inc | Daniel R. Passeri | Director, CHIEF EXECUTIVE OFFICER | 30 Sep 2021 | 31,677 | 98,700 (0%) | 0% | 14.6 | 461,534 | Common Stock | |
| Cue Biopharma Inc | Daniel R. Passeri | Director, CHIEF EXECUTIVE OFFICER | 24 Sep 2021 | 3,400 | 55,377 (0%) | 0% | 14.7 | 50,051 | Common Stock | |
| Cue Biopharma Inc | Daniel R. Passeri | Director, CEO | 10 Feb 2021 | 85,000 | 85,000 | - | - | Stock Option (right to buy) |